Pancreatic cancer is a devastating disease with both local invasion and distant metastasis. Identifying the genes expressed in liver metastases and signatures of metastatic progression would therefore be of particular importance as they could aid in both recurrence prediction as well as representing novel therapeutic targets.
S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells.
Specimen part
View SamplesPancreatic cancer is a devastating disease with both local invasion and distant metastasis. Identifying the genes expressed in liver metastases and signatures of metastatic progression would therefore be of particular importance as they could aid in both recurrence prediction as well as representing novel therapeutic targets.
S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells.
Specimen part
View SamplesWe and others have shown that S100P is highly upregulated during the progression of pancreatic cancer. We used microarrays to look at the target genes regulated by S100P in the pancreatic cancer cell line Panc1.
S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells.
Specimen part, Cell line
View SamplesBackground: With less than a 5% survival rate pancreatic adenocarcinoma (PDAC) is almost uniformly lethal. In order to make a significant impact on survival of patients with this malignancy, it is necessary to diagnose the disease early, when curative surgery is still possible. Detailed knowledge of the natural history of the disease and molecular events leading to its progression is therefore critical.
Molecular analysis of precursor lesions in familial pancreatic cancer.
Specimen part, Disease, Disease stage
View SamplesAlternative splicing is a key event to human transcriptome and proteome diversity and complexity. Recent evidence suggests that pancreatic cancer might possess particular patterns of splice variation that influence the function of individual genes contributing to tumour progression in this disease. The identification of new pancreatic cancer-associated splice variants would offer opportunities for novel diagnostics and potentially also represent novel therapeutic targets.
Splice variants as novel targets in pancreatic ductal adenocarcinoma.
Sex, Age, Specimen part
View SamplesThis SuperSeries is composed of the SubSeries listed below.
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.
Sex, Age, Specimen part
View SamplesAlternative splicing is a key event to human transcriptome and proteome diversity and complexity. Recent evidence suggests that pancreatic cancer might possess particular patterns of splice variation that influence the function of individual genes contributing to tumour progression in this disease. The identification of new pancreatic cancer-associated splice variants would offer opportunities for novel diagnostics and potentially also represent novel therapeutic targets.
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.
Sex, Age, Specimen part
View Samples